We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
-11.27%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
-$28.1M
Cap. Flow
+$13.8M
Cap. Flow %
4.83%
Top 10 Hldgs %
23.94%
Holding
291
New
20
Increased
124
Reduced
82
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Technology 12.16%
3 Industrials 10.01%
4 Financials 9.78%
5 Energy 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$609B
$12.4M 4.33%
96,072
+2,819
+3% +$393K
XOM icon
2
ExxonMobil
XOM
$611B
$8.87M 3.09%
130,002
-2,184
-2% -$171K
AAPL icon
3
Apple
AAPL
$4.9T
$7.67M 2.68%
194,408
+16,520
+9% +$801K
MSFT icon
4
Microsoft
MSFT
$2.93T
$6.87M 2.4%
67,668
+1,920
+3% +$206K
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.06T
$6.31M 2.2%
30,906
+2,180
+8% +$455K
PEP icon
6
PepsiCo
PEP
$187B
$6.26M 2.18%
56,627
+241
+0.4% +$27.2K
VZ icon
7
Verizon
VZ
$182B
$5.99M 2.09%
106,520
-818
-0.8% -$46.4K
JPM icon
8
JPMorgan Chase
JPM
$907B
$4.96M 1.73%
50,825
+1,243
+3% +$132K
T icon
9
AT&T
T
$152B
$4.96M 1.73%
230,119
+15,481
+7% +$360K
HD icon
10
Home Depot
HD
$338B
$4.33M 1.51%
25,231
+234
+0.9% +$42K
ABBV icon
11
AbbVie
ABBV
$450B
$4.21M 1.47%
45,611
-220
-0.5% -$19.3K
PG icon
12
Procter & Gamble
PG
$349B
$4.05M 1.41%
44,106
+1,424
+3% +$127K
ABT icon
13
Abbott
ABT
$175B
$3.93M 1.37%
54,278
+3,204
+6% +$225K
CVX icon
14
Chevron
CVX
$373B
$3.6M 1.25%
33,049
-450
-1% -$52.1K
GOOG icon
15
Alphabet (Google) Class C
GOOG
$4.22T
$3.54M 1.24%
68,440
+14,400
+27% +$771K
PFE icon
16
Pfizer
PFE
$143B
$3.54M 1.23%
85,360
+78
+0.1% +$3.24K
BDX icon
17
Becton Dickinson
BDX
$43.6B
$3.37M 1.18%
15,320
CVS icon
18
CVS Health
CVS
$137B
$3.19M 1.11%
48,754
+12,431
+34% +$928K
IBM icon
19
IBM
IBM
$200B
$3.06M 1.07%
28,112
+4,701
+20% +$564K
EMR icon
20
Emerson Electric
EMR
$78.2B
$2.9M 1.01%
48,580
-4,341
-8% -$293K
MRK icon
21
Merck
MRK
$315B
$2.72M 0.95%
37,358
-167
-0.4% -$11.8K
MCD icon
22
McDonald's
MCD
$190B
$2.63M 0.92%
14,796
-749
-5% -$133K
HON icon
23
Honeywell
HON
$71.3B
$2.61M 0.91%
20,994
-1,232
-6% -$168K
EPD icon
24
Enterprise Products Partners
EPD
$82.6B
$2.49M 0.87%
101,418
+24,783
+32% +$663K
BMY icon
25
Bristol-Myers Squibb
BMY
$124B
$2.44M 0.85%
46,954
-2,484
-5% -$133K

Similar funds

Boenning & Scattergood's Q4 2018 Portfolio in Review

As of Q4 2018, Boenning & Scattergood held 291 positions worth $287M, down 8.9% from $315M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boenning & Scattergood deployed $13.8M of net new capital in Q4 2018, opening 20 new positions and adding to 124 existing holdings. Its largest new stake was iShares Biotechnology ETF: 11,674 shares worth $1.13M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Starbucks, an estimated $660K trimmed.

  • Boenning & Scattergood's largest Q4 2018 buy was iShares Biotechnology ETF: 11,674 shares worth $1.13M.
  • Boenning & Scattergood added most to Universal Health Realty Income Trust in Q4 2018, an estimated $4.88M increase.
  • Boenning & Scattergood's biggest Q4 2018 reduction was Starbucks, cutting an estimated $660K.
  • Boenning & Scattergood fully exited Quanta Services in Q4 2018, selling an estimated $901K.
  • Boenning & Scattergood's ten largest holdings make up 24% of its $287M portfolio in Q4 2018.
  • Boenning & Scattergood opened 20 new positions and closed 29 in Q4 2018.
  • Boenning & Scattergood's portfolio value fell 8.9% quarter-over-quarter to $287M.

Based on Boenning & Scattergood's 13F filing for Q4 2018, filed 22 Jan 2019.